April 12th, 2011 by Peggy Polaneczky, M.D. in Health Tips, Research
Tags: Blood Clots, Breast Cancer, Heart Disease, Hormone Replacement Therapy, HRT, Should You Take HRT, Summary, WHI, Women's Health Initiative
1 Comment »
This is the study that doesn’t end…
The longterm follow up extends…
Some people started studying hormones in menopause,
And they’ll continue publishing more data just because…
(repeat)
In yet another paper in a major journal, we hear once more from the investigators of the Women’s Health Initiative. This time it’s the long term outcomes of women who took estrogen alone, now seven years out from stopping their hormones. What new information can we learn from this extensive analysis of new data?
Nothing.
Really.
The WHI’s been telling us the same thing about ERT (Estrogen replacement therapy) and HRT (Combination estrogen/progestin therapy) since 2002, and all each subsequent study does is reinforce and expand on that initial data. Unfortunately, it will probably take a few more papers before some folks accept the results of this important study, which, though flawed, continues to inform the practice of menopausal medicine.
Allow me to summarize what we know – Read more »
*This blog post was originally published at The Blog That Ate Manhattan*
April 11th, 2011 by Bryan Vartabedian, M.D. in Medblogger Shout Outs, Research
Tags: Blog, How Do Physicians Use Twitter?, JAMA, Physicians, Twitter, Uncategorized
No Comments »
It seems for many doctors Twitter activity is an outpost connected to some other online place. 48% of physicians on Twitter link to their blog according to Katherine Chretien’s recent study published in JAMA. Doctors apparently understand that different types of information flow better in different channels.
If you had asked me I would have estimated that this Twitter-blog association was much lower. Of course I like to believe that I understand the social doctor better than I actually do. And this is why we need original research like Katherine Chretien’s.
*This blog post was originally published at 33 Charts*
April 10th, 2011 by ChristopherChangMD in Health Tips, Research
Tags: Allergy, Asthma, Density, Development, ENT, Nasal Hair, Otolaryngology, Protective Effect, Risk
2 Comments »
Researchers in Turkey found that there is an association between nasal hair density and risk of asthma developing in patients with seasonal rhinitis patients. No joke… They published their findings in the International Archives of Allergy and Immunology in March 2011.
The rate of asthma found in patients with little or no nasal hair was 44.7% whereas only 16.7% of patients with a dense forest of nasal hair had asthma.
They hypothesize that increased nasal hair improves allergen filtration thereby preventing the allergens from irritating the airway. The assumption here being that allergen irritation of the airway can potentially cause asthma.
IF this is true (and that’s a big if)… patients with allergies should be encouraged to grow nice thick nasal hair to prevent future asthma!
Read the research abstract here!
Reference:
Does Nasal Hair (Vibrissae) Density Affect the Risk of Developing Asthma in Patients with Seasonal Rhinitis? Int Arch Allergy Immunol. 2011 Mar 30;156(1):75-80
*This blog post was originally published at Fauquier ENT Blog*
April 9th, 2011 by RyanDuBosar in News, Research
Tags: Airport Scanners, Archives of Internal Medicine, CT, Radiation Exposure, Radiology, Screenings
No Comments »
In preparation of Internal Medicine 2011 in San Diego this week, the unavoidable choice to make isn’t which sessions to attend, but even before arriving: Will you pass through the airport’s security scanners, or opt for the pat down?
Physicians themselves are split on the issue, with some physicians opting out of repeat scanning in favor of the pat down search.
“I do whatever I can to avoid the scanner,” one physician told CNN. Other physicians interviewed were split on the issue one way or another. But as a frequent flier, this doctor was concerned about the cumulative effect. “This is a total body scan–not a dental or chest X-ray. Total body radiation is not something I find very comforting based on my medical knowledge.” Read more »
*This blog post was originally published at ACP Internist*
April 8th, 2011 by GarySchwitzer in Opinion, Research
Tags: Drug Sales, Marketing, Off-Label Drug Use, Pharma
1 Comment »
There’s an important paper in PLoS Medicine, “Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints.” The authors provide this background on off-label marketing:
“An important part of the (drug) approval process is the creation of the “drug label,” a detailed report that specifies the exact diseases and patient groups in which the drug can be used and the approved doses of the drug.
Physicians can, however, legally use FDA-approved drugs ‘off-label.’ That is, they can prescribe drugs for a different disease, in a different group of patients, or at a different dose to that specified in the drug’s label. However, because drugs’ manufacturers stand to benefit financially from off-label use through increased drugs sales, the FDA prohibits them from directly promoting unapproved uses. The fear is that such marketing would encourage the widespread use of drugs in settings where their efficacy and safety has not been rigorously tested, exposing patients to uncertain benefits and possible adverse effects.”
The authors conclude: Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
